{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:55:59Z","timestamp":1790553359202,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12800-z","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:01:09Z","timestamp":1790488869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Empowering cancer therapy: the promise of natural adjuvants"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0374-6584","authenticated-orcid":false,"given":"Title","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5616-4238","authenticated-orcid":false,"given":"Roshni","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-6688","authenticated-orcid":false,"given":"Koustav","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"1","key":"12800_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-015-0439-8","volume":"13","author":"J Anampa","year":"2015","unstructured":"Anampa J, Makower D, Sparano JA (2015) Progress in adjuvant chemotherapy for breast cancer: an overview. BMC Med 13(1):195. https:\/\/doi.org\/10.1186\/s12916-015-0439-8","journal-title":"BMC Med"},{"issue":"1","key":"12800_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T et al (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther 8(1):283. https:\/\/doi.org\/10.1038\/s41392-023-01557-7","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"12800_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/08830185.2024.2404095","volume":"44","author":"H Gogoi","year":"2025","unstructured":"Gogoi H, Mani R, Bhatnagar R (2025) Re-inventing traditional aluminum-based adjuvants: Insight into a century of advancements. Int Rev Immunol 44(2):58\u201381. https:\/\/doi.org\/10.1080\/08830185.2024.2404095","journal-title":"Int Rev Immunol"},{"key":"12800_CR4","doi-asserted-by":"publisher","unstructured":"Singleton KL, Joffe A, Leitner WW (2023) Review: Current trends, challenges, and success stories in adjuvant research. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1105655","DOI":"10.3389\/fimmu.2023.1105655"},{"key":"12800_CR5","doi-asserted-by":"publisher","first-page":"109887","DOI":"10.1016\/j.intimp.2023.109887","volume":"117","author":"N Hashemi Goradel","year":"2023","unstructured":"Hashemi Goradel N, Nemati M, Bakhshandeh A, Arashkia A, Negahdari B (2023) Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen. Int Immunopharmacol 117:109887. https:\/\/doi.org\/10.1016\/j.intimp.2023.109887","journal-title":"Int Immunopharmacol"},{"key":"12800_CR6","first-page":"154","volume":"26","author":"EF McCarthy","year":"2006","unstructured":"McCarthy EF (2006) The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 26:154\u2013158","journal-title":"Iowa Orthop J"},{"issue":"3","key":"12800_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","volume":"12","author":"S Dong","year":"2022","unstructured":"Dong S, Guo X, Han F, He Z, Wang Y (2022) Emerging role of natural products in cancer immunotherapy. Acta Pharm Sin B 12(3):1163\u20131185. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.020","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"12800_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/vaccines13030237","volume":"13","author":"K Kie\u0142bowski","year":"2025","unstructured":"Kie\u0142bowski K, Plewa P, Zadworny J, Bakinowska E, Becht R, Pawlik A (2025) Recent Advances in the Development and Efficacy of Anti-Cancer Vaccines\u2014A Narrative Review. Vaccines (Basel) 13(3):237. https:\/\/doi.org\/10.3390\/vaccines13030237","journal-title":"Vaccines (Basel)"},{"key":"12800_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3390\/cells12172159","volume":"12","author":"M Kaczmarek","year":"2023","unstructured":"Kaczmarek M et al (2023) Cancer Vaccine Therapeutics: Limitations and Effectiveness\u2014A Literature Review. Cells 12:2159. https:\/\/doi.org\/10.3390\/cells12172159","journal-title":"Cells"},{"issue":"1","key":"12800_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12929-024-01082-x","volume":"31","author":"W-Y Chi","year":"2024","unstructured":"Chi W-Y et al (2024) Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens. J Biomed Sci 31(1):94. https:\/\/doi.org\/10.1186\/s12929-024-01082-x","journal-title":"J Biomed Sci"},{"issue":"15","key":"12800_CR11","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.3390\/molecules28155804","volume":"28","author":"LL-Y Kan","year":"2023","unstructured":"Kan LL-Y, Chan BC-L, Leung P-C, Wong C-K (2023) Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer. Molecules 28(15):5804. https:\/\/doi.org\/10.3390\/molecules28155804","journal-title":"Molecules"},{"issue":"2","key":"12800_CR12","doi-asserted-by":"publisher","first-page":"100796","DOI":"10.1016\/j.phyplu.2025.100796","volume":"5","author":"AAA Aljabali","year":"2025","unstructured":"Aljabali AAA et al (2025) Harnessing nature\u2019s potential: Exploring phytoestrogens in cervical cancer. Phytomedicine Plus 5(2):100796. https:\/\/doi.org\/10.1016\/j.phyplu.2025.100796","journal-title":"Phytomedicine Plus"},{"issue":"32","key":"12800_CR13","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.2174\/0109298673274796240116105555","volume":"31","author":"Y Vijayan","year":"2024","unstructured":"Vijayan Y, Sandhu JS, Harikumar KB (2024) Modulatory Role of Phytochemicals\/Natural Products in Cancer Immunotherapy. Curr Med Chem 31(32):5165\u20135177. https:\/\/doi.org\/10.2174\/0109298673274796240116105555","journal-title":"Curr Med Chem"},{"key":"12800_CR14","doi-asserted-by":"publisher","first-page":"126115","DOI":"10.1016\/j.vaccine.2024.07.016","volume":"42","author":"M Zou","year":"2024","unstructured":"Zou M, Lei C, Huang D, Liu L, Han Y (2024) Application of plant-derived products as adjuvants for immune activation and vaccine development. Vaccine 42:126115. https:\/\/doi.org\/10.1016\/j.vaccine.2024.07.016","journal-title":"Vaccine"},{"issue":"4","key":"12800_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/vaccines13040378","volume":"13","author":"Y Jia","year":"2025","unstructured":"Jia Y et al (2025) Plant-Derived Immunomodulatory Nanoadjuvants for Cancer Vaccines: Current Status and Future Opportunities. Vaccines (Basel) 13(4):378. https:\/\/doi.org\/10.3390\/vaccines13040378","journal-title":"Vaccines (Basel)"},{"issue":"41","key":"12800_CR16","doi-asserted-by":"publisher","first-page":"45714","DOI":"10.1021\/acsami.0c08069","volume":"12","author":"R Yuan","year":"2020","unstructured":"Yuan R, Huang Y, Chan L, He D, Chen T (2020) Engineering EHD1-Targeted Natural Borneol Nanoemulsion Potentiates Therapeutic Efficacy of Gefitinib against Nonsmall Lung Cancer. ACS Appl Mater Interfaces 12(41):45714\u201345727. https:\/\/doi.org\/10.1021\/acsami.0c08069","journal-title":"ACS Appl Mater Interfaces"},{"key":"12800_CR17","doi-asserted-by":"publisher","first-page":"106347","DOI":"10.1016\/j.ejps.2022.106347","volume":"181","author":"M Wang","year":"2023","unstructured":"Wang M et al (2023) Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy. Eur J Pharm Sci 181:106347. https:\/\/doi.org\/10.1016\/j.ejps.2022.106347","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"12800_CR18","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s00210-023-02673-5","volume":"397","author":"S Mitra","year":"2024","unstructured":"Mitra S et al (2024) Piperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer. Naunyn Schmiedebergs Arch Pharmacol 397(5):2637\u20132650. https:\/\/doi.org\/10.1007\/s00210-023-02673-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"12800_CR19","doi-asserted-by":"publisher","unstructured":"Swain SS, Sahoo SK (2024) Piperlongumine and its derivatives against cancer: A recent update and future prospective. Arch Pharm (Weinheim) 357(7). https:\/\/doi.org\/10.1002\/ardp.202300768","DOI":"10.1002\/ardp.202300768"},{"issue":"5","key":"12800_CR20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/1061186X.2024.2448708","volume":"33","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Xiong R, Hu Q, Zhang Q, Wang S, Chen Y (2025) Review on anti-tumour lipid nano drug delivery systems of traditional Chinese medicine. J Drug Target 33(5):704\u2013716. https:\/\/doi.org\/10.1080\/1061186X.2024.2448708","journal-title":"J Drug Target"},{"key":"12800_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/01635581.2020.1861310","volume":"73","author":"AT Kiddane","year":"2021","unstructured":"Kiddane AT, Kim G-D (2021) Anticancer and Immunomodulatory Effects of Polysaccharides. Nutr Cancer 73:11\u201312. https:\/\/doi.org\/10.1080\/01635581.2020.1861310","journal-title":"Nutr Cancer"},{"key":"12800_CR22","doi-asserted-by":"publisher","unstructured":"Wei J et al (2024) Natural plant-derived polysaccharides targeting macrophage polarization: a promising strategy for cancer immunotherapy. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1408377","DOI":"10.3389\/fimmu.2024.1408377"},{"key":"12800_CR23","doi-asserted-by":"publisher","unstructured":"Mayoux M et al (2020) Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy. Sci Transl Med 12(534). https:\/\/doi.org\/10.1126\/scitranslmed.aav7431","DOI":"10.1126\/scitranslmed.aav7431"},{"key":"12800_CR24","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.vaccine.2008.06.048","volume":"26","author":"K Sarkar","year":"2008","unstructured":"Sarkar K et al (2008) Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation. Vaccine 26:4352\u20134362. https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.048","journal-title":"Vaccine"},{"issue":"1","key":"12800_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12964-024-01576-z","volume":"22","author":"N Ganguly","year":"2024","unstructured":"Ganguly N et al (2024) Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NF\u03baB. Cell Communication Signal 22(1):237. https:\/\/doi.org\/10.1186\/s12964-024-01576-z","journal-title":"Cell Communication Signal"},{"issue":"11","key":"12800_CR26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.humimm.2022.08.012","volume":"83","author":"A Singh","year":"2022","unstructured":"Singh A, Chatterjee A, Rakshit S, Shanmugam G, Mohanty LM, Sarkar K (2022) Neem Leaf Glycoprotein in immunoregulation of cancer. Hum Immunol 83(11):768\u2013777. https:\/\/doi.org\/10.1016\/j.humimm.2022.08.012","journal-title":"Hum Immunol"},{"issue":"1","key":"12800_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13287-019-1349-z","volume":"10","author":"T Ghosh","year":"2019","unstructured":"Ghosh T et al (2019) NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions. Stem Cell Res Ther 10(1):296. https:\/\/doi.org\/10.1186\/s13287-019-1349-z","journal-title":"Stem Cell Res Ther"},{"key":"12800_CR28","doi-asserted-by":"publisher","unstructured":"Chakravarti M et al (2024) Neem Leaf Glycoprotein Disrupts Exhausted CD8\u2009+\u2009T-Cell\u2013Mediated Cancer Stem Cell Aggression, Molecular Cancer Res 22(8):759\u2013778. https:\/\/doi.org\/10.1158\/1541-7786.MCR-23-0993","DOI":"10.1158\/1541-7786.MCR-23-0993"},{"key":"12800_CR29","doi-asserted-by":"publisher","unstructured":"Das J et al (2024) The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study, Front Immunol 15 https:\/\/doi.org\/10.3389\/fimmu.2024.1325161","DOI":"10.3389\/fimmu.2024.1325161"},{"issue":"1","key":"12800_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13020-024-01032-7","volume":"19","author":"L Cao","year":"2024","unstructured":"Cao L, Wang X, Ma X, Xu M, Li J (2024) Potential of natural products and gut microbiome in tumor immunotherapy. Chin Med 19(1):161. https:\/\/doi.org\/10.1186\/s13020-024-01032-7","journal-title":"Chin Med"},{"issue":"11","key":"12800_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.tcb.2023.03.008","volume":"33","author":"J Liu","year":"2023","unstructured":"Liu J, Cao X (2023) Glucose metabolism of TAMs in tumor chemoresistance and metastasis. Trends Cell Biol 33(11):967\u2013978. https:\/\/doi.org\/10.1016\/j.tcb.2023.03.008","journal-title":"Trends Cell Biol"},{"issue":"7","key":"12800_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/pharmaceutics16070865","volume":"16","author":"M-Y Li","year":"2024","unstructured":"Li M-Y, Ye W, Luo K-W (2024) Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer. Pharmaceutics 16(7):865. https:\/\/doi.org\/10.3390\/pharmaceutics16070865","journal-title":"Pharmaceutics"},{"key":"12800_CR33","doi-asserted-by":"publisher","unstructured":"Noorbakhsh Varnosfaderani SM et al (2024) Potential promising anticancer applications of \u03b2-glucans: a review. Biosci Rep 44(1). https:\/\/doi.org\/10.1042\/BSR20231686","DOI":"10.1042\/BSR20231686"},{"issue":"17","key":"12800_CR34","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1080\/17435889.2025.2540775","volume":"20","author":"M Wu","year":"2025","unstructured":"Wu M, Zhang W, Song H, Hu Y, Li W (2025) Beyond biologics: fungal polysaccharides as dual-function materials for nanomedicine. Nanomedicine 20(17):2275\u20132289. https:\/\/doi.org\/10.1080\/17435889.2025.2540775","journal-title":"Nanomedicine"},{"issue":"1","key":"12800_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s42003-024-05853-y","volume":"7","author":"CW Wold","year":"2024","unstructured":"Wold CW et al (2024) Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity. Commun Biol 7(1):222. https:\/\/doi.org\/10.1038\/s42003-024-05853-y","journal-title":"Commun Biol"},{"key":"12800_CR36","doi-asserted-by":"publisher","first-page":"132986","DOI":"10.1016\/j.ijbiomac.2024.132986","volume":"273","author":"SS Ali","year":"2024","unstructured":"Ali SS et al (2024) A review of the fungal polysaccharides as natural biopolymers: Current applications and future perspective. Int J Biol Macromol 273:132986. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132986","journal-title":"Int J Biol Macromol"},{"key":"12800_CR37","doi-asserted-by":"publisher","unstructured":"Li Y, Wang X, Ma X, Liu C, Wu J, Sun C (2021) Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy. Front Pharmacol 12. https:\/\/doi.org\/10.3389\/fphar.2021.621813","DOI":"10.3389\/fphar.2021.621813"},{"key":"12800_CR38","doi-asserted-by":"publisher","unstructured":"Zheng JH et al (2017) Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med 9(376). https:\/\/doi.org\/10.1126\/scitranslmed.aak9537","DOI":"10.1126\/scitranslmed.aak9537"},{"issue":"1","key":"12800_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11033-024-10146-y","volume":"52","author":"H Afzal","year":"2025","unstructured":"Afzal H, Murtaza A, Cheng L-T (2025) Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation. Mol Biol Rep 52(1):104. https:\/\/doi.org\/10.1007\/s11033-024-10146-y","journal-title":"Mol Biol Rep"},{"key":"12800_CR40","doi-asserted-by":"publisher","unstructured":"Grayczyk JP et al (2024) TLR priming licenses NAIP inflammasome activation by immunoevasive ligands, Proceed Nat Academy Sci 121(48). https:\/\/doi.org\/10.1073\/pnas.2412700121","DOI":"10.1073\/pnas.2412700121"},{"key":"12800_CR41","doi-asserted-by":"publisher","first-page":"101330","DOI":"10.1016\/j.coviro.2023.101330","volume":"60","author":"JH Rhee","year":"2023","unstructured":"Rhee JH, Khim K, Puth S, Choi Y, Lee SE (2023) Deimmunization of flagellin adjuvant for clinical application. Curr Opin Virol 60:101330. https:\/\/doi.org\/10.1016\/j.coviro.2023.101330","journal-title":"Curr Opin Virol"},{"key":"12800_CR42","doi-asserted-by":"publisher","unstructured":"Shi P et al (2022) Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.1001553","DOI":"10.3389\/fphar.2022.1001553"},{"issue":"3","key":"12800_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12016-019-08752-x","volume":"58","author":"A Zahirovi\u0107","year":"2020","unstructured":"Zahirovi\u0107 A, Luzar J, Molek P, Kruljec N, Lunder M (2020) Bee Venom Immunotherapy: Current Status and Future Directions. Clin Rev Allergy Immunol 58(3):326\u2013341. https:\/\/doi.org\/10.1007\/s12016-019-08752-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"12800_CR44","doi-asserted-by":"publisher","first-page":"105329","DOI":"10.1016\/j.bioorg.2021.105329","volume":"116","author":"GH Mansour","year":"2021","unstructured":"Mansour GH et al (2021) Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells. Bioorg Chem 116:105329. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105329","journal-title":"Bioorg Chem"},{"issue":"1","key":"12800_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W et al (2020) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther 5(1):87. https:\/\/doi.org\/10.1038\/s41392-020-0187-x","journal-title":"Signal Transduct Target Ther"},{"key":"12800_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jconrel.2024.08.047","volume":"375","author":"X Duan","year":"2024","unstructured":"Duan X, Zou H, Yang J, Liu S, Xu T, Ding J (2024) Melittin-incorporated nanomedicines for enhanced cancer immunotherapy. J Controlled Release 375:285\u2013299. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.047","journal-title":"J Controlled Release"},{"key":"12800_CR47","doi-asserted-by":"publisher","first-page":"17709","DOI":"10.1007\/s00432-023-05458-8","volume":"149","author":"S Haque","year":"2023","unstructured":"Haque S et al (2023) Melittin: a possible regulator of cancer proliferation in preclinical cell culture and animal models. J Cancer Res Clin Oncol 149:17709\u201317726. https:\/\/doi.org\/10.1007\/s00432-023-05458-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"22","key":"12800_CR48","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.3390\/polym14224931","volume":"14","author":"AS Silva","year":"2022","unstructured":"Silva AS et al (2022) Silk Sericin: A Promising Sustainable Biomaterial for Biomedical and Pharmaceutical Applications. Polym (Basel) 14(22):4931. https:\/\/doi.org\/10.3390\/polym14224931","journal-title":"Polym (Basel)"},{"key":"12800_CR49","doi-asserted-by":"publisher","first-page":"121638","DOI":"10.1016\/j.biomaterials.2022.121638","volume":"287","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Silk sericin-based materials for biomedical applications. Biomaterials 287:121638. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121638","journal-title":"Biomaterials"},{"key":"12800_CR50","doi-asserted-by":"publisher","first-page":"154369","DOI":"10.1016\/j.prp.2023.154369","volume":"243","author":"S Rahimpour","year":"2023","unstructured":"Rahimpour S et al (2023) Regulatory effect of sericin protein in inflammatory pathways; A comprehensive review. Pathol Res Pract 243:154369. https:\/\/doi.org\/10.1016\/j.prp.2023.154369","journal-title":"Pathol Res Pract"},{"key":"12800_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202400145","author":"\u0141 Mazurek","year":"2024","unstructured":"Mazurek \u0141, Rybka M, Jurak J, Frankowski J, Konop M (2024) Silk Sericin and Its Effect on Skin Wound Healing: A State of the Art. Macromol Biosci. https:\/\/doi.org\/10.1002\/mabi.202400145","journal-title":"Macromol Biosci"},{"issue":"2","key":"12800_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/nano12020186","volume":"12","author":"A-G Niculescu","year":"2022","unstructured":"Niculescu A-G, Grumezescu AM (2022) Applications of Chitosan-Alginate-Based Nanoparticles\u2014An Up-to-Date Review. Nanomaterials 12(2):186. https:\/\/doi.org\/10.3390\/nano12020186","journal-title":"Nanomaterials"},{"key":"12800_CR53","doi-asserted-by":"publisher","unstructured":"Bo Y, Wang H (2024) Biomaterial-Based In Situ Cancer Vaccines. Adv Mater 36(43). https:\/\/doi.org\/10.1002\/adma.202210452","DOI":"10.1002\/adma.202210452"},{"key":"12800_CR54","doi-asserted-by":"publisher","unstructured":"Desai N, Gotru S, Salave S, Vora LK (2025) Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications. Front Biomaterials Sci 4. https:\/\/doi.org\/10.3389\/fbiom.2025.1544465","DOI":"10.3389\/fbiom.2025.1544465"},{"key":"12800_CR55","doi-asserted-by":"publisher","unstructured":"Huang M et al (2024) T cell senescence: a new perspective on immunotherapy in lung cancer. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1338680","DOI":"10.3389\/fimmu.2024.1338680"},{"issue":"1","key":"12800_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1567201813666160804121123","volume":"14","author":"D Li","year":"2017","unstructured":"Li D et al (2017) Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine. Curr Drug Deliv 14(1):27\u201335. https:\/\/doi.org\/10.2174\/1567201813666160804121123","journal-title":"Curr Drug Deliv"},{"key":"12800_CR57","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.2147\/IJN.S165876","volume":"13","author":"A Malik","year":"2018","unstructured":"Malik A, Gupta M, Gupta V, Gogoi H, Bhatnagar R (2018) Novel application of trimethyl chitosan as an adjuvant in vaccine delivery. Int J Nanomed 13:7959\u20137970. https:\/\/doi.org\/10.2147\/IJN.S165876","journal-title":"Int J Nanomed"},{"key":"12800_CR58","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijbiomac.2021.12.129","volume":"200","author":"I Dmour","year":"2022","unstructured":"Dmour I, Islam N (2022) Recent advances on chitosan as an adjuvant for vaccine delivery. Int J Biol Macromol 200:498\u2013519. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.12.129","journal-title":"Int J Biol Macromol"},{"key":"12800_CR59","doi-asserted-by":"publisher","first-page":"118050","DOI":"10.1016\/j.carbpol.2021.118050","volume":"264","author":"X Li","year":"2021","unstructured":"Li X et al (2021) Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants. Carbohydr Polym 264:118050. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118050","journal-title":"Carbohydr Polym"},{"key":"12800_CR60","doi-asserted-by":"publisher","unstructured":"Gao Y, Guo Y (2023) Research progress in the development of natural-product-based mucosal vaccine adjuvants. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1152855","DOI":"10.3389\/fimmu.2023.1152855"},{"key":"12800_CR61","doi-asserted-by":"publisher","unstructured":"Gong X, Gao Y, Shu J, Zhang C, Zhao K (1906) Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines, Vaccines (Basel) 10(11):2022. https:\/\/doi.org\/10.3390\/vaccines10111906","DOI":"10.3390\/vaccines10111906"},{"key":"12800_CR62","doi-asserted-by":"publisher","unstructured":"Wang P (2021) Natural and Synthetic Saponins as Vaccine Adjuvants, Vaccines (Basel) 9(3):222. https:\/\/doi.org\/10.3390\/vaccines9030222","DOI":"10.3390\/vaccines9030222"},{"issue":"1","key":"12800_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08923973.2014.971963","volume":"37","author":"AH Banday","year":"2015","unstructured":"Banday AH, Jeelani S, Hruby VJ (2015) Cancer vaccine adjuvants \u2013 recent clinical progress and future perspectives. Immunopharmacol Immunotoxicol 37(1):1\u201311. https:\/\/doi.org\/10.3109\/08923973.2014.971963","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"12800_CR64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41570-020-00244-3","volume":"5","author":"C Pifferi","year":"2021","unstructured":"Pifferi C, Fuentes R, Fern\u00e1ndez-Tejada A (2021) Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nat Rev Chem 5(3):197\u2013216. https:\/\/doi.org\/10.1038\/s41570-020-00244-3","journal-title":"Nat Rev Chem"},{"key":"12800_CR65","doi-asserted-by":"publisher","unstructured":"Murphy EJ et al (2023) Polysaccharides\u2014Naturally Occurring Immune Modulators, Polymers (Basel) 15(10):2373. https:\/\/doi.org\/10.3390\/polym15102373","DOI":"10.3390\/polym15102373"},{"key":"12800_CR66","doi-asserted-by":"publisher","first-page":"101780","DOI":"10.1016\/j.tranon.2023.101780","volume":"37","author":"A Aboussekhra","year":"2023","unstructured":"Aboussekhra A, Alraouji NN, Al-Mohanna FH, Al-Khalaf H (2023) Ionizing radiation normalizes the features of active breast cancer stromal fibroblasts and suppresses their paracrine pro-carcinogenic effects. Transl Oncol 37:101780. https:\/\/doi.org\/10.1016\/j.tranon.2023.101780","journal-title":"Transl Oncol"},{"issue":"7","key":"12800_CR67","doi-asserted-by":"publisher","first-page":"94907534","DOI":"10.26599\/NR.2025.94907534","volume":"18","author":"M Li","year":"2025","unstructured":"Li M, Li W, Li Z, Lu J (2025) Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines. Nano Res 18(7):94907534. https:\/\/doi.org\/10.26599\/NR.2025.94907534","journal-title":"Nano Res"},{"key":"12800_CR68","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijpharm.2018.11.008","volume":"554","author":"P Gu","year":"2019","unstructured":"Gu P et al (2019) Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses. Int J Pharm 554:72\u201380. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.11.008","journal-title":"Int J Pharm"},{"key":"12800_CR69","doi-asserted-by":"publisher","unstructured":"Yao P, Liang S, Liu Z, Xu C (2024) A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1343316","DOI":"10.3389\/fimmu.2024.1343316"},{"key":"12800_CR70","doi-asserted-by":"publisher","unstructured":"Kayraklioglu N, Horuluoglu B, Klinman DM (2021) CpG Oligonucleotides as Vaccine Adjuvants. 51\u201385. https:\/\/doi.org\/10.1007\/978-1-0716-0872-2_4","DOI":"10.1007\/978-1-0716-0872-2_4"},{"key":"12800_CR71","doi-asserted-by":"publisher","unstructured":"Mata-Mart\u00ednez P, Berg\u00f3n-Guti\u00e9rrez M, Fresno Cdel (2022) Dectin-1 Signaling Update: New Perspectives for Trained Immunity. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.812148","DOI":"10.3389\/fimmu.2022.812148"},{"key":"12800_CR72","doi-asserted-by":"publisher","first-page":"155608","DOI":"10.1016\/j.phymed.2024.155608","volume":"129","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zeng Y, Yang W, Wang X, Jiang J (2024) Targeting CD8\u2009+\u2009T cells with natural products for tumor therapy: Revealing insights into the mechanisms. Phytomedicine 129:155608. https:\/\/doi.org\/10.1016\/j.phymed.2024.155608","journal-title":"Phytomedicine"},{"issue":"1","key":"12800_CR73","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40779-024-00586-9","volume":"11","author":"Y Godiyal","year":"2024","unstructured":"Godiyal Y et al (2024) Role of PD-1\/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy. Mil Med Res 11(1):82. https:\/\/doi.org\/10.1186\/s40779-024-00586-9","journal-title":"Mil Med Res"},{"issue":"1","key":"12800_CR74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T et al (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther 8(1):283. https:\/\/doi.org\/10.1038\/s41392-023-01557-7","journal-title":"Signal Transduct Target Ther"},{"key":"12800_CR75","doi-asserted-by":"publisher","unstructured":"Wu X, Feng N, Wang C, Jiang H, Guo Z (2024) Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1444452","DOI":"10.3389\/fimmu.2024.1444452"},{"key":"12800_CR76","doi-asserted-by":"publisher","unstructured":"Deng R et al (2025) Promises of natural products as clinical applications for cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1880(1):189241. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189241","DOI":"10.1016\/j.bbcan.2024.189241"},{"issue":"1","key":"12800_CR77","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41467-024-45358-0","volume":"15","author":"KF Bol","year":"2024","unstructured":"Bol KF et al (2024) Adjuvant dendritic cell therapy in stage IIIB\/C melanoma: the MIND-DC randomized phase III trial. Nat Commun 15(1):1632. https:\/\/doi.org\/10.1038\/s41467-024-45358-0","journal-title":"Nat Commun"},{"key":"12800_CR78","doi-asserted-by":"publisher","first-page":"122252","DOI":"10.1016\/j.carbpol.2024.122252","volume":"339","author":"L He","year":"2024","unstructured":"He L, Zhu Z, Qi C (2024) \u03b2-Glucan\u2014A promising immunocyte-targeting drug delivery vehicle: Superiority, applications and future prospects. Carbohydr Polym 339:122252. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122252","journal-title":"Carbohydr Polym"},{"key":"12800_CR79","doi-asserted-by":"publisher","first-page":"129581","DOI":"10.1016\/j.ijbiomac.2024.129581","volume":"260","author":"AD Gholap","year":"2024","unstructured":"Gholap AD et al (2024) Exploring modified chitosan-based gene delivery technologies for therapeutic advancements. Int J Biol Macromol 260:129581. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129581","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"12800_CR80","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12951-024-02590-6","volume":"22","author":"L-M Cao","year":"2024","unstructured":"Cao L-M et al (2024) Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions. J Nanobiotechnol 22(1):308. https:\/\/doi.org\/10.1186\/s12951-024-02590-6","journal-title":"J Nanobiotechnol"},{"issue":"20","key":"12800_CR81","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.3390\/cancers13205048","volume":"13","author":"I Chmielewska","year":"2021","unstructured":"Chmielewska I, Stencel K, Kalinka E, Ramlau R, Krawczyk P (2021) Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer\u2014Clinical Trials Experience. Cancers (Basel) 13(20):5048. https:\/\/doi.org\/10.3390\/cancers13205048","journal-title":"Cancers (Basel)"},{"issue":"15","key":"12800_CR82","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3390\/cancers17152507","volume":"17","author":"RK Singla","year":"2025","unstructured":"Singla RK, Bishayee A (2025) Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies. Cancers (Basel) 17(15):2507. https:\/\/doi.org\/10.3390\/cancers17152507","journal-title":"Cancers (Basel)"},{"key":"12800_CR83","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/bph.14816","volume":"177","author":"S Lin","year":"2020","unstructured":"Lin S et al (2020) Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br J Pharmacol 177:1409\u20131423. https:\/\/doi.org\/10.1111\/bph.14816","journal-title":"Br J Pharmacol"},{"key":"12800_CR84","doi-asserted-by":"publisher","unstructured":"Mansouri H, Irchad A, Rubaka C, Kisula L, Hamza AA, Sauli E (2026) Botanical Adjuvants in Oncology: A Review on Natural Compounds in Synergy with Conventional Therapies as Next-Generation Enhancers of Breast Cancer Treatment. Curr Issues Mol Biol 48(2). https:\/\/doi.org\/10.3390\/cimb48020170","DOI":"10.3390\/cimb48020170"},{"key":"12800_CR85","doi-asserted-by":"publisher","unstructured":"Kilgore PB, Sha J, Hendrix EK, Motin VL, Chopra AK (2021) Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague. mBio 12(6). https:\/\/doi.org\/10.1128\/mBio.03223-21","DOI":"10.1128\/mBio.03223-21"},{"key":"12800_CR86","doi-asserted-by":"publisher","unstructured":"Verma SK et al (2023) New-age vaccine adjuvants, their development, and future perspective. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1043109","DOI":"10.3389\/fimmu.2023.1043109"},{"issue":"3","key":"12800_CR87","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/med.21876","volume":"42","author":"Z Zhong","year":"2022","unstructured":"Zhong Z et al (2022) Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets. Med Res Rev 42(3):1246\u20131279. https:\/\/doi.org\/10.1002\/med.21876","journal-title":"Med Res Rev"},{"key":"12800_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70375","author":"R Hu","year":"2026","unstructured":"Hu R et al (2026) Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.70375","journal-title":"Br J Pharmacol"},{"issue":"7","key":"12800_CR89","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/jpm14070685","volume":"14","author":"V Conti","year":"2024","unstructured":"Conti V et al (2024) Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy. J Pers Med 14(7):685. https:\/\/doi.org\/10.3390\/jpm14070685","journal-title":"J Pers Med"},{"issue":"3","key":"12800_CR90","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/med.21876","volume":"42","author":"Z Zhong","year":"2022","unstructured":"Zhong Z et al (2022) Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets. Med Res Rev 42(3):1246\u20131279. https:\/\/doi.org\/10.1002\/med.21876","journal-title":"Med Res Rev"},{"issue":"3","key":"12800_CR91","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1007\/s12011-024-04266-6","volume":"203","author":"A Pandey","year":"2025","unstructured":"Pandey A, Karmous I (2025) Exploring the Potential of Plant-Based Nanotechnology in Cancer Immunotherapy: Benefits, Limitations, and Future Perspectives. Biol Trace Elem Res 203(3):1746\u20131763. https:\/\/doi.org\/10.1007\/s12011-024-04266-6","journal-title":"Biol Trace Elem Res"},{"issue":"12","key":"12800_CR92","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/polym10121407","volume":"10","author":"S Minzanova","year":"2018","unstructured":"Minzanova S et al (2018) Biological Activity and Pharmacological Application of Pectic Polysaccharides: A Review. Polym (Basel) 10(12):1407. https:\/\/doi.org\/10.3390\/polym10121407","journal-title":"Polym (Basel)"},{"key":"12800_CR93","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.vaccine.2004.03.022","volume":"22","author":"WJW Morrow","year":"2004","unstructured":"Morrow WJW, Yang Y-W, Sheikh NA (2004) Immunobiology of the Tomatine adjuvant. Vaccine 22:2380\u20132384. https:\/\/doi.org\/10.1016\/j.vaccine.2004.03.022","journal-title":"Vaccine"},{"issue":"12","key":"12800_CR94","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.4049\/jimmunol.175.12.8051","volume":"175","author":"NK Crellin","year":"2005","unstructured":"Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK (2005) Human CD4\u2009+\u2009T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4\u2009+\u2009CD25+ T Regulatory Cells. J Immunol 175(12):8051\u20138059. https:\/\/doi.org\/10.4049\/jimmunol.175.12.8051","journal-title":"J Immunol"},{"issue":"5","key":"12800_CR95","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jsps.2023.03.016","volume":"31","author":"H Ali","year":"2023","unstructured":"Ali H et al (2023) Virosome: An engineered virus for vaccine delivery. Saudi Pharm J 31(5):752\u2013764. https:\/\/doi.org\/10.1016\/j.jsps.2023.03.016","journal-title":"Saudi Pharm J"},{"issue":"1","key":"12800_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13567-017-0442-5","volume":"48","author":"IA Hajam","year":"2017","unstructured":"Hajam IA, Dar PA, Won G, Lee JH (2017) Bacterial ghosts as adjuvants: mechanisms and potential. Vet Res 48(1):37. https:\/\/doi.org\/10.1186\/s13567-017-0442-5","journal-title":"Vet Res"},{"issue":"9","key":"12800_CR97","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/plants12091782","volume":"12","author":"AP Mishra","year":"2023","unstructured":"Mishra AP et al (2023) Role of the Dietary Phytochemical Curcumin in Targeting Cancer Cell Signalling Pathways. Plants 12(9):1782. https:\/\/doi.org\/10.3390\/plants12091782","journal-title":"Plants"},{"issue":"6","key":"12800_CR98","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/ijms20061305","volume":"20","author":"B Salehi","year":"2019","unstructured":"Salehi B et al (2019) The Therapeutic Potential of Apigenin. Int J Mol Sci 20(6):1305. https:\/\/doi.org\/10.3390\/ijms20061305","journal-title":"Int J Mol Sci"},{"issue":"2","key":"12800_CR99","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/biom10020221","volume":"10","author":"M Abotaleb","year":"2020","unstructured":"Abotaleb M, Liskova A, Kubatka P, B\u00fcsselberg D (2020) Therapeutic Potential of Plant Phenolic Acids in the Treatment of Cancer. Biomolecules 10(2):221. https:\/\/doi.org\/10.3390\/biom10020221","journal-title":"Biomolecules"},{"key":"12800_CR100","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ebiom.2016.11.019","volume":"15","author":"M Skwarczynski","year":"2017","unstructured":"Skwarczynski M (2017) Inulin: A New Adjuvant With Unknown Mode of Action. EBioMedicine 15:8\u20139. https:\/\/doi.org\/10.1016\/j.ebiom.2016.11.019","journal-title":"EBioMedicine"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12800-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12800-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12800-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:01:53Z","timestamp":1790550113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12800-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12800"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12800-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"31 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1627"}}